Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey

Background Fungal infections remain a substantial cause of mortality in lung transplant (LTx) recipients, yet no comprehensive consensus guidelines have been established for antifungal prophylaxis and treatment of Aspergillus infection in these patients. Methods A cross‐sectional study surveyed the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplant infectious disease 2015-02, Vol.17 (1), p.14-20
Hauptverfasser:	He, S.Y., Makhzoumi, Z.H., Singer, J.P., Chin-Hong, P.V., Arron, S.T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amphotericin B - therapeutic use Antifungal Agents - therapeutic use antifungal prophylaxis Aspergillosis - prevention & control Aspergillus - drug effects Aspergillus colonization Aspergillus prophylaxis Cross-Sectional Studies Humans invasive aspergillosis lung transplant recipients lung transplantation Lung Transplantation - adverse effects Pre-Exposure Prophylaxis squamous cell carcinoma Surveys and Questionnaires United States Voriconazole - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!